About

About Creatv Bio Creatv provides innovative blood tests for detecting and diagnosing cancer when it matters most. Our LifeTracDx® blood test is applicable to all solid tumors, all stages of cancer and all therapies. LifeTracDx® liquid biopsy can screen for cancer and provide prognosis at the same time. • Screen for single cancer or pan cancers even high percentage in stage 1 • Detect minimal residual disease at end of therapy • Detect recurrence earlier than imaging while not requiring tumor to grow larger LifeTracDx® liquid biopsy can also provide diagnostics for patients with cancer. • Provide companion/complementary diagnostics – simpler and cheaper than tissue biopsy, such as immunotherapy • Provide prognosis at any time • Predict treatment response to new therapy just 30 days after first treatment • Monitor therapy identification of drug resistance • Provide copious unfragmented tumor DNA for sequencing Clinical applications of these highly sensitive and specific tests will reduce morbidity and significantly improve patient outcomes. Our LifeTracDx® blood test will not only benefit patients, but also ideally suited for cancer drug development and clinical trials.